The successful introduction of a programme to reduce the use of i.v. ciprofloxacin in hospital.
The effectiveness of a programme to reduce the use of i.v. ciprofloxacin was assessed. i.v. ciprofloxacin was removed from ward stock and discussion occurred regarding appropriate use of the drug. Six months later, a factsheet containing recommendations was distributed to all medical staff and a requirement for justification before prescription was introduced. The programme reduced expenditure on i.v. ciprofloxacin to 34% of original levels. Savings of > 36,000 pounds sterling were made for two consecutive years. A sustained reduction in the use of i.v. ciprofloxacin was obtained by a combination of education and restriction.
Weller
T M A
TM
Department of Microbiology, City Hospital NHS Trust, Dudley Road, Birmingham B18 7QH, UK. T.M.A.Weller@bham.ac.uk
D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000191:economics*; D002939:Ciprofloxacin / Q000008:administration & dosage / Q000191:economics*; D017046:Cost Savings; D004363:Drug Utilization; D007275:Injections, Intravenous; D010607:Pharmacy Service, Hospital / Q000458:organization & administration*; D010606:Pharmacy and Therapeutics Committee; D006113:United Kingdom
D000890:Anti-Infective Agents; D002939:Ciprofloxacin